As U.S. cases rise, a new nationally representative panel survey by the Annenberg Public Policy Center (APPC) of the University of Pennsylvania finds a small but significant drop in the proportion of the public that would recommend that someone in their household get the MMR vaccine, which protects against measles, mumps, and rubella. The survey of 1,637 U.S. adults, which was conducted Nov. 17-Dec. 1, 2025, finds drops in both the perceived safety and effectiveness of the MMR vaccine, as well as for two other vaccines, for seasonal flu and Covid-19. The public does, however, continue to see vaccination as the best defense against diseases like the measles. See the end of this news release or the topline for additional details.
The survey data come from the 26th wave of a nationally representative panel of 1,637 U.S. adults conducted for the Annenberg Public Policy Center by SSRS, an independent market research company. This wave of the Annenberg Science and Public Health Knowledge (ASAPH) survey was fielded Nov. 17-Dec. 1, 2025. The margin of sampling error (MOE) is ± 3.5 percentage points at the 95% confidence level. All figures are rounded to the nearest whole number and may not add to 100%. Combined subcategories may not add to totals in the topline and text due to rounding.